We are live on ! Find out more
Qube Research & Technologies (QRT)

Qube Research & Technologies (QRT) Portfolio holdings

AUM $89.9B
1-Year Est. Return 20.22%
This Fund
S&P 500
This Quarter Est. Return
+6.9%
1 Year Est. Return
+20.22%
3 Year Est. Return
+42.42%
5 Year Est. Return
+23.97%
10 Year Est. Return
–
AUM
$98.4B
AUM Growth
+$12.2B
Cap. Flow
+$4.67B
Cap. Flow %
4.75%
Top 10 Hldgs %
7.81%
Holding
4,101
New
656
Increased
1,629
Reduced
1,101
Closed
596

Top Buys

Rank Stock Value
1
TMO icon
Thermo Fisher Scientific
TMO
+$486M
2
AAPL icon
Apple
AAPL
+$485M
3
BMY icon
Bristol-Myers Squibb
BMY
+$479M
4
UBER icon
Uber
UBER
+$376M
5
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$363M

Top Sells

Rank Stock Value
1
AVGO icon
Broadcom
AVGO
+$1.02B
2
META icon
Meta Platforms (Facebook)
META
+$675M
3
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$545M
4
MSFT icon
Microsoft
MSFT
+$482M
5
AMAT icon
Applied Materials
AMAT
+$404M

Sector Composition

Rank Sector Weight
1 Technology 13.24%
2 Financials 10.53%
3 Industrials 10.31%
4 Healthcare 10.01%
5 Consumer Discretionary 9.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HXL icon
3726
Hexcel
HXL
$8.32B
– –
-163,351
Closed -$8.95M
IAT icon
3727
iShares US Regional Banks ETF
IAT
$685M
– –
-227
Closed -$10.6K
ICF icon
3728
iShares Select U.S. REIT ETF
ICF
$2.12B
– –
-2,739
Closed -$169K
IDR icon
3729
Idaho Strategic Resources
IDR
$449M
– –
-34,088
Closed -$488K
IEZ icon
3730
iShares US Oil Equipment & Services ETF
IEZ
$367M
– –
-10,394
Closed -$203K
IHE icon
3731
iShares US Pharmaceuticals ETF
IHE
$1.47B
– –
-204
Closed -$14.4K
IKT icon
3732
Inhibikase Therapeutics
IKT
$366M
– –
-35,625
Closed -$78K
ILCB icon
3733
iShares Morningstar US Equity ETF
ILCB
$1.26B
– –
-169
Closed -$13.1K
ILCG icon
3734
iShares Morningstar Growth ETF
ILCG
$3.1B
– –
-807
Closed -$65.4K
ILMN icon
3735
Illumina
ILMN
$29.4B
– –
-127,273
Closed -$10.3M
IMKTA icon
3736
Ingles Markets
IMKTA
$1.63B
– –
-8,317
Closed -$542K
IMUX icon
3737
Immunic
IMUX
$182M
– –
-3,499
Closed -$38.1K
INDV icon
3738
Indivior Pharmaceuticals
INDV
$4.79B
– –
-239,389
Closed -$2.28M
INN
3739
Summit Hotel Properties
INN
$761M
– –
-161,609
Closed -$874K
INSG icon
3740
Inseego
INSG
$108M
– –
-64,419
Closed -$526K
INSW icon
3741
International Seaways
INSW
$4.57B
– –
-37,863
Closed -$1.26M
INTF icon
3742
iShares International Equity Factor ETF
INTF
$3.54B
– –
-1,855
Closed -$57.2K
INZY
3743
DELISTED
Inozyme Pharma
INZY
– –
-80,006
Closed -$72.8K
IOVA icon
3744
Iovance Biotherapeutics
IOVA
$2.23B
– –
-972,689
Closed -$3.24M
IPAC icon
3745
iShares Core MSCI Pacific ETF
IPAC
$2.6B
– –
-1,230
Closed -$76.6K
IPAR icon
3746
Interparfums
IPAR
$3.92B
– –
-7,705
Closed -$877K
IRBT
3747
DELISTED
iRobot
IRBT
– –
-238,268
Closed -$643K
ISSC icon
3748
Innovative Solutions & Support
ISSC
$342M
– –
-18,225
Closed -$115K
ITA icon
3749
iShares US Aerospace & Defense ETF
ITA
$14.2B
– –
-458
Closed -$70.1K
ITIC
3750
Investors Title Co
ITIC
$533M
– –
-860
Closed -$207K
148 149
150
151 152

Similar funds

Focus Partners Wealth
Focus Partners Wealth Boston, Massachusetts $89.9B AUM 20.5% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $92.9B AUM 36.98% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return
Cetera Investment Advisers
Cetera Investment Advisers Schaumburg, Illinois $94B AUM 20.14% 1-Year Est. Return
Mariner
Mariner Overland Park, Kansas $85.7B AUM 24.21% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
California State Teachers Retirement System (CalSTRS)
California State Teachers Retirement System (CalSTRS) West Sacramento, California $94.5B AUM 29.33% 1-Year Est. Return

Qube Research & Technologies (QRT)'s Q2 2025 Portfolio in Review

As of Q2 2025, Qube Research & Technologies (QRT) held 4,101 positions worth $98.4B, up 14% from $86.2B the previous quarter. Its ten largest holdings account for 7.8% of the portfolio.

Qube Research & Technologies (QRT) deployed $4.67B of net new capital in Q2 2025, opening 656 new positions and adding to 1,629 existing holdings. Its largest new stake was Bristol-Myers Squibb: 9,752,683 shares worth $451M.

By sector, the portfolio is most concentrated in Technology at 13% of assets, down from 15% a quarter earlier, followed by Financials and Industrials.

On the sell side, the largest reduction was Meta Platforms (Facebook), an estimated $675M trimmed.

  • Qube Research & Technologies (QRT)'s largest Q2 2025 buy was Bristol-Myers Squibb: 9,752,683 shares worth $451M.
  • Qube Research & Technologies (QRT) added most to Thermo Fisher Scientific in Q2 2025, an estimated $486M increase.
  • Qube Research & Technologies (QRT)'s biggest Q2 2025 reduction was Meta Platforms (Facebook), cutting an estimated $675M.
  • Qube Research & Technologies (QRT) fully exited Broadcom in Q2 2025, selling an estimated $1.02B.
  • Qube Research & Technologies (QRT)'s ten largest holdings make up 7.8% of its $98.4B portfolio in Q2 2025.
  • Qube Research & Technologies (QRT) opened 656 new positions and closed 596 in Q2 2025.
  • Qube Research & Technologies (QRT)'s portfolio value rose 14% quarter-over-quarter to $98.4B.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2025, filed 14 Aug 2025.